L01XE Protein kinase inhibitors

RX_L01XE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — L01XE 1 out of 7 registries used, show all original rules.	2002
4. Check minimum number of events Min. number of events 3	2002
5. Include endpoints None	2002
6. Filter based on genotype QC (FinnGen only)	1926

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	RX_L01XE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	L01XE
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to L01XE Protein kinase inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

ILD medications: nintedanib

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1926	1012	914
Unadjusted period prevalence (%)	0.39	0.36	0.42
Median age at first event (years)	67.55	66.02	69.23

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2002: Matched controls
20020

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L01XE01

ATC

[U] imatinib

+∞

309.6

289

189

Kela drug reimbursment

Imatinib

1146.0

308.6

294

L01XE04

ATC

[U] sunitinib

1726.6

308.4

292

Z51.5

ICD-10 Finland

Palliative care

12.4

307.7

791

1002

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

58.4

307.7

251

H02AB02

ATC

dexamethasone; systemic

8.8

307.7

844

1524

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

28.3

307.7

689

365

A03FA01

ATC

metoclopramide; systemic, rectal

10.6

307.7

1309

3027

284

Kela drug reimbursment

Nintedanib and pirfenidone

93.8

307.7

195

L02BA03

ATC

fulvestrant; parenteral

72.6

307.7

243

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

20.5

307.7

330

191

L01XE33

ATC

[U] palbociclib

4122.9

307.7

354

A04AA02

ATC

granisetron; systemic, transdermal

8.5

307.7

499

750

N02AA05

ATC

oxycodone; systemic

8.1

307.7

1091

2569

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

20.8

307.7

372

217

197

Kela drug reimbursment

Sunitinib

302.6

307.7

329

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

19.3

307.7

272

162

JN4AD

NOMESCO Finland

Body CT examination

6.9

307.7

659

1338

L01EF01

ATC

palbociclib; oral

112.5

307.7

184

1501

Kela drug reimbursment

Palbociclib

216.3

307.7

356

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

105.8

307.7

174

130

Kela drug reimbursment

Malignant tumour

19.5

307.7

1071

1114

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

28.8

307.7

226

394

Kela drug reimbursment

Palbociclib

186.0

307.7

314

192

Kela drug reimbursment

Fulvestrant

99.8

307.7

222

WF049

NOMESCO Finland

Radiotherapy of metastasis

25.7

307.7

623

346

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

141.4

307.7

611

JN4BD

NOMESCO Finland

Extensive body CT

13.1

307.7

977

1359

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

13.4

307.7

449

423

KAC10

NOMESCO Finland

Total nephrectomy with capsule

42.8

303.1

183

M05BX04

ATC

denosumab; parenteral

8.1

302.6

468

723

198

Kela drug reimbursment

Sorafenib

157.4

294.2

146

356

Kela drug reimbursment

Nintedanib and pirfenidone

71.9

293.0

159

JN4CD

NOMESCO Finland

Very extensive body CT

10.4

292.2

355

407

A04AA01

ATC

ondansetron; systemic, rectal

7.0

287.2

526

971

WF004

NOMESCO Finland

Palliative radiotherapy

16.2

285.5

253

177

1502

Kela drug reimbursment

Cabozantinib

107.4

272.3

140

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

22.4

271.5

204

101

L02BG06

ATC

exemestane; oral

17.8

261.6

219

137

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

28.0

260.9

179

3012

Kela drug reimbursment

Cabozantinib

102.5

259.2

134

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

8.8

258.2

357

480

322

Kela drug reimbursment

Sunitinib

137.8

257.0

129

L01CA04

ATC

vinorelbine; systemic

26.2

249.0

175

L01BC06

ATC

capecitabine; oral

8.8

238.8

328

436

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

21.9

232.1

175

L03AA02

ATC

filgrastim; parenteral

10.0

221.9

270

307

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.8

221.0

339

511

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

11.4

218.8

240

236

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

14.8

218.7

202

151

L01EX09

ATC

nintedanib; oral

102.7

206.9

107

L01XE31

ATC

[U] nintedanib

+∞

205.9

194

WW500

NOMESCO Finland

Blood transfusion

8.3

205.5

292

402

115

Kela drug reimbursment

Breast cancer

5.6

200.3

452

996

L02BG04

ATC

letrozole; oral

6.3

198.9

383

728

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

7.8

193.6

293

433

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

6.2

186.7

361

687

L02BA01

ATC

tamoxifen; oral

7.9

184.3

273

393

WZC00

NOMESCO Finland

Treatment plan or consultation

3.7

183.0

1150

5316

159

Kela drug reimbursment

Pazopanib

391.6

181.7

180

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

8.0

180.6

262

368

X76

ICPC

Malignant neoplasm breast female

12.3

180.3

186

166

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

15.7

172.3

152

104

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

19.0

171.4

137

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

365.1

170.0

169

176

Kela drug reimbursment

Regorafenib

55.4

167.3

L03AA13

ATC

pegfilgrastim; parenteral

6.8

166.0

283

473

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.4

163.2

511

1454

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

18.4

161.4

131

ZX120

NOMESCO Finland

Intravenous

4.7

160.4

441

1134

L01XE11

ATC

[U] pazopanib

1628.6

154.2

148

WZC30

NOMESCO Finland

Teaching

3.8

154.1

644

2239

L04AX05

ATC

pirfenidone; oral

51.1

152.5

158

Kela drug reimbursment

Everolimus

404.7

152.3

151

AA1BD

NOMESCO Finland

Extensive CT of head and brain

8.9

149.5

195

240

L01EA01

ATC

imatinib; oral

779.3

149.2

145

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.5

147.3

1378

7781

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

21.3

146.7

111

HAC20

NOMESCO Finland

Total mastectomy

6.9

144.3

239

386

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

8.0

141.8

203

279

316

Kela drug reimbursment

Imatinib

1452.5

140.3

135

XW000

NOMESCO Finland

Bone marrow biopsy

6.2

139.9

259

468

NK6AN

NOMESCO Finland

Total body bone isotope imaging

7.8

139.6

204

287

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.6

135.7

369

933

L01EX07

ATC

cabozantinib; oral

53.3

134.6

A79

ICPC

Malignancy NOS

11.5

134.4

143

133

R50.9

ICD-10 Finland

Fever, unspecified

3.7

133.7

545

1844

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.0

131.3

315

718

L01XE05

ATC

[U] sorafenib

456.5

130.5

129

155

Kela drug reimbursment

Afatinib and gefitinib

1286.1

125.4

121

369

Kela drug reimbursment

Regorafenib

43.2

125.2

L01XE26

ATC

[U] cabozantinib

1229.6

120.1

116

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

10.5

119.3

135

137

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

119.3

493

1671

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

40.3

114.8

A06AH03

ATC

naloxegol; oral

10.5

114.8

130

132

191

Kela drug reimbursment

Erlotinib

306.5

114.3

115

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

10.2

114.2

132

138

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.0

114.0

268

598

XX3DW

NOMESCO Finland

Time consuming IT work

3.6

113.7

451

1484

L01XE03

ATC

[U] erlotinib

585.1

113.1

111

L01XE23

ATC

[U] dabrafenib

1151.0

112.7

109

ZX090

NOMESCO Finland

Other technic of radiotherapy

6.7

110.9

184

296

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

384.6

110.5

110

L01XE10

ATC

[U] everolimus

+∞

109.4

104

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

32.0

109.2

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.0

104.3

246

549

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

6.2

103.2

186

325

U75

ICPC

Malignant neoplasm of kidney

47.5

102.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

32.5

102.0

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.8

101.6

120

129

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

16.6

101.5

1CD02, ,

NOMESCO Finland

13.8

101.2

A04AD12

ATC

aprepitant; systemic

8.1

100.6

140

185

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

5.8

99.6

194

365

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.6

99.6

394

1286

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

34.2

98.9

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

21.0

96.3

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

96.3

970

5274

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

8.7

96.2

125

152

168

Kela drug reimbursment

Axitinib

973.5

95.8

HA1AA

NOMESCO Finland

X-ray mammography

4.0

95.7

308

872

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

+∞

95.6

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

4.5

95.4

254

624

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.6

94.8

139

195

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

962.5

94.7

L01XX05

ATC

hydroxycarbamide; oral

10.3

94.1

107

109

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

10.7

93.9

104

102

B01AB10

ATC

tinzaparin; parenteral

3.5

92.9

380

1263

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

12.0

92.7

L01XE27

ATC

[U] ibrutinib

940.5

92.6

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

27.8

91.1

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

4.9

90.3

213

474

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

11.4

89.9

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

24.5

89.8

TGC00

NOMESCO Finland

Bronchial lavation

6.7

89.7

148

236

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.6

87.9

337

1072

B01AB05

ATC

enoxaparin; parenteral

2.5

87.0

908

4956

180

Kela drug reimbursment

Interferon alfa

27.6

86.5

390

Kela drug reimbursment

Ibrutinib

157.0

85.8

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

6.4

85.1

146

242

L01XE13

ATC

[U] afatinib

+∞

85.0

L03AB05

ATC

interferon alfa-2b; parenteral

27.9

83.9

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

15.3

83.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.4

83.6

228

569

N02AA01

ATC

morphine; systemic, rectal

7.9

82.9

116

154

L01XE25

ATC

[U] trametinib

+∞

82.9

A04AA55

ATC

palonosetron, combinations; systemic

5.3

81.6

175

358

J94.8

ICD-10 Finland

Other specified pleural conditions

8.6

80.5

105

128

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.6

80.4

294

904

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

8.8

80.3

103

123

340

Kela drug reimbursment

Everolimus

213.6

79.9

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

78.7

728

3719

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

12.7

77.3

1512

Kela drug reimbursment

Ibrutinib

140.6

76.5

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

6.8

76.2

122

188

C50.99

ICD-10 Finland

Breast, unspecified

5.7

76.2

147

273

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

75.9

700

3561

ZX050

NOMESCO Finland

Stereotactic radiotherapy

11.9

73.4

A02BC02

ATC

pantoprazole; systemic

2.8

73.2

1599

11821

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.8

72.8

117

181

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

10.8

71.3

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

13.6

71.0

L01XE18

ATC

[U] ruxolitinib

712.6

70.5

JN6AD

NOMESCO Finland

CT of torso and neck

7.8

70.4

132

C03CA01

ATC

furosemide; systemic

2.3

69.4

816

4581

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

6.6

69.3

115

184

B01AB04

ATC

dalteparin; parenteral

4.1

67.8

203

541

L01XE21

ATC

[U] regorafenib

86.6

67.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.9

66.9

154

334

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

27.1

65.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

65.3

269

888

J01MA12

ATC

levofloxacin; systemic

2.5

65.3

542

2599

174

Kela drug reimbursment

Ruxolitinib

173.2

64.4

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

7.0

64.0

100

150

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.2

64.0

138

283

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.7

63.9

123

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

12.5

63.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

13.1

63.3

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

8.2

62.9

108

R84

ICPC

Malignant neoplasm bronchus/lung

20.9

62.0

L01XE17

ATC

[U] axitinib

+∞

61.8

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

113.7

61.2

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

13.2

60.7

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.7

60.4

116

214

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.1

60.3

131

270

361

Kela drug reimbursment

Axitinib

605.8

60.0

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

19.2

59.8

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

19.6

59.0

H02AB06

ATC

prednisolone; systemic

2.1

58.1

1120

7490

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

16.9

57.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.9

56.9

315

1228

341

Kela drug reimbursment

Afatinib and gefitinib

+∞

56.5

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

13.6

56.3

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

123.7

56.1

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

123.7

56.1

152

Kela drug reimbursment

Nilotinib

563.3

55.9

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

11.2

55.7

L02BG03

ATC

anastrozole; oral

6.7

55.2

138

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.6

54.9

194

578

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

16.8

54.9

J01MA14

ATC

moxifloxacin; systemic

2.9

54.6

283

1063

150

Kela drug reimbursment

Dasatinib

+∞

54.4

ZX112

NOMESCO Finland

Subcutaneous

5.5

54.2

108

206

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

9.4

54.1

374

Kela drug reimbursment

Ruxolitinib

146.6

54.1

343

Kela drug reimbursment

Pazopanib

146.6

54.1

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.8

53.7

127

281

L01XX28

ATC

[U] imatinib

+∞

53.4

L01EX01

ATC

sunitinib; oral

77.4

53.3

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

5.3

52.9

110

218

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

7.1

51.9

115

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

14.1

51.1

L01XE07

ATC

[U] lapatinib

181.4

51.1

E0000UV, ,

ATC

2.0

50.8

931

6013

156

Kela drug reimbursment

Lapatinib

261.8

50.3

L01XE06

ATC

[U] dasatinib

+∞

50.2

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

18.5

50.0

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

15.7

49.5

M04AA01

ATC

allopurinol; systemic

2.4

49.2

389

1799

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

6.9

49.0

116

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

48.9

209

701

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

10.2

47.9

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

47.8

573

3149

L01XE02

ATC

[U] gefitinib

478.9

47.5

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

5.4

47.4

182

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

7.3

47.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

47.1

464

2357

L01EL01

ATC

ibrutinib; oral

128.1

47.0

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

15.5

46.9

PJA12

NOMESCO Finland

Sentinel node biopsy

2.8

45.4

254

990

L01EJ01

ATC

ruxolitinib; oral

160.3

45.0

323

Kela drug reimbursment

Sorafenib

59.3

44.5

B03XA02

ATC

darbepoetin alfa; parenteral

5.0

44.0

206

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

10.0

43.7

GD1AD

NOMESCO Finland

Thorax CT examination

3.1

43.7

197

681

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

6.4

43.4

118

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

82.0

43.0

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

17.8

42.9

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.9

42.9

218

806

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

7.2

42.5

L01EG02

ATC

everolimus; oral

219.6

42.0

ZX080

NOMESCO Finland

Image guided radiotherapy

4.6

41.1

222

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

11.0

40.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

40.8

288

1257

L01XE08

ATC

[U] nilotinib

+∞

40.8

TQW20

NOMESCO Finland

Tatoe

8.1

40.6

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

9.3

40.5

FM1FN

NOMESCO Finland

Heart function isotope examination

11.6

39.7

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

10.0

39.3

A06AD11

ATC

lactulose; oral

2.2

39.1

382

1918

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

39.1

367

1814

3004

Kela drug reimbursment

Osimertinib

107.2

38.9

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

4.4

38.7

229

R4190

NOMESCO Finland

Nutritional therapy

3.9

38.6

117

313

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.0

38.5

113

295

L01EK01

ATC

axitinib; oral

384.5

38.2

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

6.8

37.9

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

37.8

161

537

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

9.5

37.2

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

11.3

37.2

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

4.6

37.1

203

R4110

NOMESCO Finland

Physiotherapy

1.9

37.0

656

4079

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

4.5

37.0

216

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

7.5

37.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

36.0

484

2735

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

6.6

35.9

L01EF03

ATC

abemaciclib; oral

48.8

35.7

SPAT1109

SPAT

Analgesia with portable analgesic pump

9.9

35.7

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

7.6

35.3

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

10.4

35.2

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3.1

34.9

155

530

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

13.4

34.9

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

6.3

34.1

328

Kela drug reimbursment

Nilotinib

342.8

34.0

XG410

NOMESCO Finland

Flow-volume spirometry

3.4

34.0

130

406

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

9.9

33.9

WB501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of primary tumour

94.3

33.8

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

5.7

33.7

113

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

7.7

33.6

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

11.5

33.6

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.6

33.6

117

344

L01AX03

ATC

temozolomide; systemic

9.1

33.4

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.7

33.3

189

738

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.9

33.1

156

3016

Kela drug reimbursment

Binimetinib and encorafenib

332.4

33.0

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.6

32.9

201

815

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

4.2

32.9

219

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

4.7

32.8

165

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.9

32.8

169

627

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

7.0

32.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.9

32.7

167

617

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

9.7

32.4

1515, ,

Kela drug reimbursment

55.3

32.3

3030

Kela drug reimbursment

Abemaciclib

55.3

32.3

L03AA14

ATC

lipegfilgrastim; parenteral

4.7

32.1

164

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.2

32.1

133

1519, ,

Kela drug reimbursment

73.4

31.9

WF002

NOMESCO Finland

Radical radiotherapy

2.7

31.8

177

684

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

9.0

31.6

324

Kela drug reimbursment

Dasatinib

+∞

31.3

3001

Kela drug reimbursment

Alectinib

+∞

31.3

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

11.2

31.2

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

10.2

31.0

1513

Kela drug reimbursment

Binimetinib and encorafenib

317.7

30.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.2

30.8

126

410

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.8

30.7

150

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

6.2

30.7

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

5.5

30.6

109

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

5.1

30.4

128

R18

ICD-10 Finland

Ascites

4.4

30.4

180

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

12.2

29.9

L01EA03

ATC

nilotinib; oral

306.9

29.9

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.7

29.6

264

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.7

29.5

170

668

L01EB03

ATC

afatinib; oral

+∞

29.2

1504

Kela drug reimbursment

Alectinib

+∞

29.2

N03AX14

ATC

levetiracetam; systemic

3.6

28.4

267

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.6

28.4

148

Z31.5

ICD-10 Finland

Genetic counselling

3.1

28.1

119

395

L01EB04

ATC

osimertinib; oral

65.0

28.0

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

9.1

27.7

WF003

NOMESCO Finland

Adjuvant radiotherapy

3.2

27.6

110

352

TGA30

NOMESCO Finland

Thoracocentesis

7.5

27.2

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

4.0

27.2

205

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

26.8

784

5527

169

Kela drug reimbursment

Crizotinib

274.6

26.8

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

5.5

26.5

JDA63

NOMESCO Finland

Local excision of lesion of stomach

46.4

26.5

L01EC02

ATC

dabrafenib; oral

60.9

26.0

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

9.8

25.0

D45

ICD-10 Finland

Polycythaemia vera

5.9

24.5

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

8.0

24.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

8.9

24.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

24.1

282

L01XE35

ATC

[U] osimertinib

+∞

24.0

L01XE36

ATC

[U] alectinib

+∞

24.0

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

5.1

23.8

100

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.5

23.8

C10AA07

ATC

rosuvastatin; oral

0.5

23.8

304

5110

L01XE16

ATC

[U] crizotinib

242.8

23.7

212

Kela drug reimbursment

Gout

4.1

23.7

166

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

6.3

23.7

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

42.0

23.6

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.7

23.6

130

499

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

23.5

570

3794

Z2446

NOMESCO Finland

Social worker

2.5

23.4

156

657

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

4.6

23.4

125

SPAT1255

SPAT

Intravenous administration of medicine

2.3

23.3

179

804

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

8.9

23.3

Z3231

NOMESCO Finland

Registered nurse

1.7

23.1

583

3919

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.3

23.1

274

ZX070

NOMESCO Finland

Intensity modified radiotherapy

3.9

23.0

174

L01ED03

ATC

alectinib; oral

+∞

23.0

L01EA02

ATC

dasatinib; oral

+∞

23.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

23.0

274

1465

H03AA01

ATC

levothyroxine sodium; systemic

1.7

22.9

493

3174

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

9.4

22.7

WX892

NOMESCO Finland

Monitored bed care

2.2

22.7

197

933

B03XA01

ATC

erythropoietin; parenteral

6.6

22.6

L01EX05

ATC

regorafenib; oral

45.6

22.4

JFB00

NOMESCO Finland

Partial resection of small intestine

4.4

22.3

130

127

Kela drug reimbursment

Transplant complication

4.7

22.2

110

N05CF01

ATC

zopiclone; oral

1.6

22.2

676

4761

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.2

22.0

140

A28

ICPC

Limited function/disability NOS

1.8

21.9

399

2444

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.7

21.7

L01EX03

ATC

pazopanib; oral

116.3

21.6

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.8

21.6

114

428

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

5.3

21.6

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

4.7

21.5

109

C50

ICD-10 Finland

Malignant neoplasm of breast

3.6

21.5

211

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

21.5

270

1468

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

19.1

21.3

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

21.0

21.3

L02AE03

ATC

goserelin; implant

5.1

21.2

L01EX02

ATC

sorafenib; oral

50.6

21.1

L01EE01

ATC

trametinib; oral

50.6

21.1

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.9

21.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

21.1

1004

7827

R11

ICD-10 Finland

Nausea and vomiting

2.2

20.9

190

916

L01XE29

ATC

[U] lenvatinib

+∞

20.9

ZX100

NOMESCO Finland

Oral

4.6

20.8

108

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

5.1

20.7

WW200, ,

SPAT

0.5

20.7

165

3275

1BA04, ,

NOMESCO Finland

212.1

20.6

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

22.6

20.4

5BA08, ,

NOMESCO Finland

7.5

20.4

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

7.5

20.4

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

4.7

20.4

102

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.6

20.3

126

513

L01BB05

ATC

fludarabine; systemic

32.9

20.2

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

20.0

170

3301

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

21.0

19.9

372

Kela drug reimbursment

Idelalisib

+∞

19.8

L01XE15

ATC

[U] vemurafenib

+∞

19.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

19.7

147

652

C64.80

ICD-10 Finland

Wilms tumour

29.2

19.6

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

4.3

19.6

122

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3.6

19.5

181

J01DB01

ATC

cefalexin; oral

1.7

19.4

1624

14307

NF3AA

NOMESCO Finland

Femur X-ray examination

3.6

19.3

187

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

19.3

264

1476

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

19.2

135

583

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

19.2

146

653

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

4.2

19.1

120

WW200

NOMESCO Finland

Immunization

3.3

18.8

220

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

18.7

249

1377

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.0

18.7

135

Z3226

NOMESCO Finland

Physiotherapist

1.7

18.7

387

2448

B73

ICPC

Leukaemia

23.9

18.6

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

21.0

18.6

C49.4

ICD-10 Finland

Malignant neoplasm: Connective and soft tissue of abdomen

191.7

18.6

ZXE00

NOMESCO Finland

One hour or less

1.5

18.5

765

5727

ZXA00

NOMESCO Finland

Right side

1.6

18.4

574

4030

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

16.3

18.3

N02BE01

ATC

paracetamol; systemic, rectal

1.9

18.3

1793

16327

SPAT1088

SPAT

Blood transfusion

6.9

18.3

D77

ICPC

Malignant digestive neopl other/NOS

7.5

18.3

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

3.7

18.2

156

3019

Kela drug reimbursment

Lenvatinib

53.0

18.0

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

53.0

18.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

17.8

771

5815

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.5

17.8

178

399

Kela drug reimbursment

Venetoclax

23.0

17.7

L01XX52

ATC

venetoclax; oral

23.0

17.7

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

23.0

17.7

N02AX02

ATC

tramadol; systemic, rectal

1.5

17.7

887

6902

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.4

17.6

102

335

Kela drug reimbursment

Lapatinib

95.9

17.6

H02AB09

ATC

hydrocortisone; systemic

3.3

17.6

199

N03AX16

ATC

[U] pregabalin

1.6

17.4

492

3368

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.6

17.3

KAC00

NOMESCO Finland

Nephrectomy

14.0

17.3

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

6.4

17.1

AA1AD

NOMESCO Finland

CT of head and brain

1.6

17.1

588

4208

OAB43, ,

SPAT

0.4

17.1

2077

L01BC59

ATC

trifluridine, combinations; systemic

13.4

17.0

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

16.8

147

697

1508

Kela drug reimbursment

Lenvatinib

63.9

16.7

1XC14, ,

NOMESCO Finland

171.4

16.5

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

27.8

16.5

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

13.5

16.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

14.4

16.3

KAD00

NOMESCO Finland

Partial nephrectomy

6.6

16.2

SPAT1269

SPAT

Other puncture and/or drainage

6.6

16.2

XX9XW, ,

NOMESCO Finland

6.6

16.2

ZZF00

NOMESCO Finland

Graft of adipose tissue

5.5

16.2

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

12.9

16.2

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.5

16.1

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.8

16.1

286

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

24.7

16.0

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

4.4

16.0

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

6.2

15.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

15.9

344

2193

E83.50

ICD-10 Finland

Hypercalcemia

4.1

15.9

106

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.9

15.9

271

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.1

15.7

D70.89

ICD-10 Finland

Neutropenic splenomegaly

4.3

15.7

D07AA02

ATC

hydrocortisone; topical

1.8

15.7

248

1447

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

13.0

15.7

L01XX47

ATC

[U] idelalisib

+∞

15.6

L01XE41

ATC

[U] binimetinib

+∞

15.6

L01XE46

ATC

[U] encorafenib

+∞

15.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

15.6

614

4509

L03AB04

ATC

interferon alfa-2a; parenteral

19.4

15.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

15.5

349

B03BA03

ATC

hydroxocobalamin; parenteral

2.2

15.5

129

599

325

Kela drug reimbursment

Erlotinib

161.2

15.5

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

15.5

791

6126

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

5.8

15.4

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

3.7

15.4

136

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

12.4

15.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

6.7

15.3

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

5.9

15.3

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.5

15.2

178

3145

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.9

15.2

114

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.9

15.2

N05AD01

ATC

haloperidol; systemic

3.0

15.2

239

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.3

15.1

115

514

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

4.1

14.9

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

11.4

14.8

SPAT1254

SPAT

Administration of medicine

1.7

14.6

293

1828

L01EC03

ATC

encorafenib; oral

80.7

14.6

C10AX09

ATC

ezetimibe; oral

0.5

14.5

120

2381

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

14.5

826

6509

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.7

14.5

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.5

14.4

356

5BX04, ,

NOMESCO Finland

19.3

14.2

ZXA05

NOMESCO Finland

Left side

1.5

14.2

514

3695

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.4

14.1

397

ZZR10

NOMESCO Finland

Flap of skin and muscle

4.8

14.0

R06AE07

ATC

cetirizine; oral

1.5

13.9

786

6171

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

15.9

13.9

8936/1-C16.9

ICD-O-3

Gastrointestinal stromal tumor, NOS, of stomach, NOS

53.7

13.8

1XC07, ,

NOMESCO Finland

11.5

13.8

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.0

13.8

198

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.5

13.7

166

2913

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

12.1

13.6

170

Kela drug reimbursment

Bosutinib

+∞

13.6

363

Kela drug reimbursment

Crizotinib

140.9

13.5

L01EE03

ATC

binimetinib; oral

140.9

13.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

3.8

13.4

106

1518, ,

Kela drug reimbursment

18.3

13.4

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

25.9

13.4

Z94.2

ICD-10 Finland

Lung transplant status

21.3

13.3

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

21.3

13.3

ZX108

NOMESCO Finland

Inhalation

5.4

13.3

3002

Kela drug reimbursment

Ribociclib

40.3

13.2

1514, ,

Kela drug reimbursment

40.3

13.2

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

13.1

175

967

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

13.0

137

698

1XC03, ,

NOMESCO Finland

10.1

13.0

GDG10

NOMESCO Finland

Bilateral transplantation of lung

28.6

13.0

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

19.2

12.9

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

19.2

12.9

9960/3-C42.1

ICD-O-3

Myeloproliferative neoplasm, NOS, of bone marrow

22.7

12.9

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.0

12.9

195

TQW99

NOMESCO Finland

Other minor procedure on skin

2.1

12.9

123

604

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

12.8

326

2160

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

4.8

12.6

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

5.5

12.6

9875/3-C42.1

ICD-O-3

Chronic myelogenous leukemia, BCR/ABL positive of bone marrow

+∞

12.5

1XC17, ,

NOMESCO Finland

+∞

12.5

ZX121

NOMESCO Finland

Central venous catheter

9.4

12.5

8936/1-C17.9

ICD-O-3

Gastrointestinal stromal tumor, NOS, of small intestine, NOS

130.8

12.4

8936/3-C17.9

ICD-O-3

Gastrointestinal stromal tumor of small intestine, NOS

130.8

12.4

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

13.3

12.4

C20

ICD-10 Finland

Malignant neoplasm of rectum

5.1

12.4

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

4.4

12.4

V03AE01

ATC

polystyrene sulfonate; oral

3.9

12.4

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

3.9

12.4

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

4.7

12.4

N05BA04

ATC

oxazepam; oral

1.5

12.3

480

3491

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

9.7

12.2

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.7

12.2

252

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

12.5

12.1

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

12.1

300

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

26.9

12.0

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

21.4

12.0

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

3.0

11.9

182

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.9

11.9

1XC02, ,

NOMESCO Finland

4.9

11.9

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

11.9

102

480

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

5.4

11.8

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.3

11.8

131

TQB05

NOMESCO Finland

Puncture of skin of trunk

4.3

11.7

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.1

11.7

157

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.4

11.7

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

4.8

11.7

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

5.5

11.6

L01EF02

ATC

ribociclib; oral

30.2

11.6

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

12.6

11.6

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

11.6

365

2533

C17.1

ICD-10 Finland

Malignant neoplasm: Jejunum

23.0

11.6

L04AA06

ATC

mycophenolic acid; systemic

3.3

11.5

133

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.6

11.5

258

3860

L01EB01

ATC

gefitinib; oral

+∞

11.5

L01XE14

ATC

[U] bosutinib

+∞

11.5

PHE70

NOMESCO Finland

Thrombectomy of inferior vena cava

120.7

11.4

TGD00

NOMESCO Finland

Needle biopsy of lung

5.4

11.4

TJA10

NOMESCO Finland

Laparocentesis

8.9

11.3

A05AA02

ATC

ursodeoxycholic acid; oral

3.7

11.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

11.2

204

1236

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

17.1

11.2

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

5.6

11.2

ZX114

NOMESCO Finland

Intramuscular

3.5

11.2

106

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.2

11.1

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

5.3

11.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

11.0

487

3622

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.9

10.9

180

HAB40

NOMESCO Finland

Wedge excision of mammary gland

2.0

10.9

117

601

J01CA04

ATC

amoxicillin; systemic

1.4

10.8

1516

13689

GD1AA, ,

SPAT

0.3

10.8

1111

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

17.9

10.7

J05AB11

ATC

valaciclovir; oral

1.6

10.7

273

1804

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

10.7

188

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.6

10.6

256

3777

JAH00

NOMESCO Finland

Laparotomy

2.6

10.6

241

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

10.6

100

490

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

11.3

10.5

C43

ICD-10 Finland

Malignant melanoma of skin

9.2

10.5

OAA67, ,

SPAT

0.3

10.5

1065

M907, C6488,

ICD-10 Finland

110.6

10.4

L01ED01

ATC

crizotinib; oral

+∞

10.4

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

12.1

10.3

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

12.1

10.3

J02AC03

ATC

voriconazole; systemic

12.1

10.3

N07BC02

ATC

methadone; systemic

8.2

10.3

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

8.2

10.3

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.2

10.3

122

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

10.6

10.3

Z51.88

ICD-10 Finland

Other specified medical care

2.8

10.3

181

C83.1

ICD-10 Finland

Mantle cell lymphoma

9.6

10.3

L02AB02

ATC

medroxyprogesterone; systemic

4.7

10.2

BCA30

NOMESCO Finland

Unilateral adrenalectomy

23.5

10.2

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.8

10.2

187

A46

ICD-10 Finland

Erysipelas

1.6

10.2

290

1966

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.3

10.1

118

ZXD05

NOMESCO Finland

Urgent procedure

1.4

10.1

540

4144

WPB10

NOMESCO Finland

Making a convalescent care decision

7.9

10.1

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

8.5

10.0

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

10.0

129

705

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

14.6

10.0

L01

ICPC

Neck symptom/complaint

0.5

10.0

102

1896

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

10.0

314

2175

8000/3-C64.9

ICD-O-3

Neoplasm, malignant of kidney, NOS

40.3

10.0

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

10.0

155

2549

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

16.8

9.9

HAD40

NOMESCO Finland

Mastopexy

8.2

9.8

C10AA05

ATC

atorvastatin; oral

0.7

9.8

585

7292

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

9.6

9.8

Z2221

NOMESCO Finland

Medical doctor

1.4

9.7

493

3745

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.4

9.7

1140

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

9.7

209

1326

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

9.7

500

C92.9

ICD-10 Finland

Myeloid leukaemia, unspecified

55.3

9.6

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

9.6

412

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.3

9.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

9.6

129

715

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

5.0

9.6

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

4.5

9.6

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

3.7

9.5

S50

ICPC

Skin, Medication/prescr/renewal

4.6

9.5

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

9.1

9.5

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

15.1

9.5

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

7.6

9.4

C16.29

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

30.2

9.4

1XC13, ,

NOMESCO Finland

17.6

9.4

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

17.6

9.4

SPAT1290

SPAT

Preparation of deceased person

12.4

9.4

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

21.8

9.3

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.0

9.3

135

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

10.7

9.3

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.7

9.3

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

4.1

9.2

Z51.0

ICD-10 Finland

Radiotherapy session

3.1

9.2

120

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

7.3

9.2

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.9

9.1

153

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

9.1

303

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.6

9.1

193

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

5.0

9.1

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

4.4

9.1

WF099

NOMESCO Finland

Other radiotherapy

4.6

9.1

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

11.5

9.1

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

15.6

9.0

L01EX08

ATC

lenvatinib; oral

36.9

9.0

N06DX01

ATC

memantine; oral

0.3

9.0

814

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

9.0

282

1951

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

4.4

8.9

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

6.8

8.8

JMA10

NOMESCO Finland

Transabdominal total splenectomy

4.7

8.8

P20

ICPC

Memory disturbance

0.5

8.8

111

1937

S77

ICPC

Malignant neoplasm of skin

3.2

8.8

103

1CD01, ,

NOMESCO Finland

9.5

8.8

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

9.5

8.8

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

8.8

137

2255

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

14.1

8.7

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

14.1

8.7

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

14.1

8.7

J96.1

ICD-10 Finland

Chronic respiratory failure

2.6

8.7

192

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

50.2

8.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

8.7

288

2015

L01AA01

ATC

cyclophosphamide; systemic

6.6

8.7

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.0

8.6

D75.2

ICD-10 Finland

Essential thrombocytosis

4.6

8.6

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2.5

8.6

211

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

8.6

501

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

16.4

8.5

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

16.4

8.5

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

16.4

8.5

R83

ICPC

Respiratory infection other

0.6

8.5

162

2540

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

7.0

8.5

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

7.0

8.5

EB4VA, ,

NOMESCO Finland

0.4

8.5

1036

X19

ICPC

Breast lump/mass female

3.2

8.5

105

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

3.2

8.5

105

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.4

8.5

255

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

20.1

8.5

J01FF01

ATC

clindamycin; systemic

1.4

8.5

495

3842

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

7.4

8.4

8936/3-C26.9

ICD-O-3

Gastrointestinal stromal tumor of gastrointestinal tract, NOS

90.4

8.4

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

8.4

160

982

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

12.8

8.4

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.4

8.4

M05BA02

ATC

clodronic acid; systemic

4.7

8.4

373

Kela drug reimbursment

Ponatinib

+∞

8.3

360

Kela drug reimbursment

Bosutinib

+∞

8.3

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

2.5

8.3

202

M25.5

ICD-10 Finland

Pain in joint

0.7

8.3

332

4457

3AA13, ,

NOMESCO Finland

10.8

8.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

3.8

8.2

R06.0

ICD-10 Finland

Dyspnoea

1.4

8.2

512

4016

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

4.8

8.1

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.5

8.1

199

ZX122

NOMESCO Finland

Intra-arterial

8.2

8.1

C34.02

ICD-10 Finland

Malignant tumor of the main bronchial adenocarcinoma

33.5

8.1

HAE99

NOMESCO Finland

Other reconstruction of breast

4.0

8.1

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

9.0

8.0

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

9.0

8.0

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.2

8.0

288

NG1AA, ,

SPAT

0.2

8.0

597

HA1RA, ,

SPAT

0.2

8.0

368

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

7.3

8.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

7.9

423

L82

ICD-10 Finland

Seborrhoeic keratosis

0.6

7.9

174

2640

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.5

7.9

189

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.2

7.9

302

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

3.7

7.9

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

4.5

7.9

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

4.6

7.9

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

13.1

7.9

D72.9

ICD-10 Finland

Disorder of white blood cells, unspecified

7.8

7.9

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.9

7.8

127

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

4.1

7.8

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

10.8

7.8

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

7.0

7.8

M90.7

ICD-10 Finland

Fracture of bone in neoplastic disease

45.2

7.7

NAR00

NOMESCO Finland

Complete excision of tumour of bone or cartilage of spine, unspecified

45.2

7.7

XX4BW, ,

NOMESCO Finland

15.1

7.7

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

15.1

7.7

TPX15

NOMESCO Finland

Removal of vascular injection port

6.4

7.7

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

3.5

7.7

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.2

7.7

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.3

7.7

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

7.6

140

852

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

8.1

7.6

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

8.1

7.6

207

Kela drug reimbursment

Chronic arrhythmias

0.6

7.5

153

2364

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

8.9

7.5

X21

ICPC

Breast sympt/compl female other

2.7

7.5

141

ZZA00

NOMESCO Finland

Split skin graft

2.2

7.5

276

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.6

7.4

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

80.4

7.4

WC501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of local recurrence of tumour

80.4

7.4

WX721

NOMESCO Finland

Oxygen concentrator therapy

7.7

7.4

OAB48, ,

SPAT

0.4

7.3

947

E000001, ,

ATC

1.4

7.3

324

2391

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

8.4

7.3

JLC10

NOMESCO Finland

Distal pancreatectomy

8.4

7.3

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.4

7.3

209

L01EB02

ATC

erlotinib; oral

+∞

7.3

WB502

NOMESCO Finland

Demanding pharmacotherapy for primary neoplasm, enzyme inhibitor or similar agent

+∞

7.3

3026

Kela drug reimbursment

Lorlatinib

+∞

7.3

3017

Kela drug reimbursment

Brigatinib

+∞

7.3

8936/3-C17.1

ICD-O-3

Gastrointestinal stromal tumor of jejunum

+∞

7.3

WA010

NOMESCO Finland

Adjuvant whole body radiotherapy

+∞

7.3

JN4DD

NOMESCO Finland

Scout CT scan of torso

10.9

7.3

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

10.9

7.3

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

6.8

7.3

JAH01

NOMESCO Finland

Laparoscopy

2.0

7.3

367

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

7.2

105

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

2.9

7.2

116

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

7.2

403

A07AA02

ATC

nystatin; oral

1.8

7.2

112

650

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

7.2

453

OAB42, ,

SPAT

0.5

7.2

1191

1XC08, ,

NOMESCO Finland

30.1

7.1

C95.9

ICD-10 Finland

Leukaemia, unspecified

30.1

7.1

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.6

7.1

157

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.6

7.1

157

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.4

7.1

187

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

7.1

618

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

6.6

7.1

D76

ICPC

Malignant neoplasm pancreas

6.6

7.1

L01AA02

ATC

chlorambucil; oral

7.9

7.1

B01AF01

ATC

rivaroxaban; oral

0.6

7.1

114

1866

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

2.3

7.1

231

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

12.1

7.1

GDB10

NOMESCO Finland

Wedge resection of lung

12.1

7.1

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

12.1

7.1

SPAT1262

SPAT

Handing over of treatment supplies

1.4

7.0

330

2460

M01AH05

ATC

etoricoxib; oral

0.8

7.0

865

9909

C83.00

ICD-10 Finland

Lymphocytic lymphoma

10.1

7.0

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

10.1

7.0

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

7.0

245

L15

ICPC

Knee symptom/complaint

0.7

7.0

244

3371

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.4

7.0

201

B81

ICPC

Anaemia vit B12/folate deficiency

2.0

7.0

394

L08

ICPC

Shoulder symptom/complaint

0.7

6.9

220

3095

N06DA02

ATC

donepezil; oral

0.3

6.9

654

GDC00

NOMESCO Finland

Lobectomy of lung

5.5

6.9

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

6.9

358

2715

A98

ICPC

Health maint/preventive medicine

0.7

6.9

1755

18268

A10BK03

ATC

empagliflozin; oral

0.5

6.9

1344

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

11.0

6.8

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

11.0

6.8

WX726

NOMESCO Finland

High-flow oxygen therapy

9.3

6.8

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

40.2

6.8

8140/3-C34.2

ICD-O-3

Adenocarcinoma, NOS, of middle lobe, lung

40.2

6.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

6.7

252

1802

L71

ICPC

Malignant neoplasm musculoskeletal

16.7

6.7

ZY010

NOMESCO Finland

Hospital outpatient

1.9

6.7

406

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

3.2

6.7

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

3.9

6.7

F51.0

ICD-10 Finland

Nonorganic insomnia

0.6

6.7

1656

KAC01

NOMESCO Finland

Percutaneous endoscopic nephrectomy

22.6

6.7

L04AX03

ATC

methotrexate; systemic

0.5

6.6

1134

GX1D5

NOMESCO Finland

Flow volume spirometry

8.7

6.5

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

8.7

6.5

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

4.2

6.5

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.5

6.5

164

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

6.5

1278

11589

M54.5

ICD-10 Finland

Low back pain

0.7

6.5

402

5060

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

6.2

6.5

8936/1-C17.1

ICD-O-3

Gastrointestinal stromal tumor, NOS, of jejunum

70.1

6.4

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

7.4

6.4

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

7.4

6.4

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

6.4

162

1068

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

14.3

6.4

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

4.1

6.4

GAA31

NOMESCO Finland

Thoracoscopy

8.2

6.3

ND2AA, ,

SPAT

0.2

6.3

317

L73.8

ICD-10 Finland

Other specified follicular disorders

3.6

6.3

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

6.0

6.3

OAB91, ,

SPAT

0.2

6.3

321

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

5.5

6.3

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

11.1

6.3

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

11.1

6.3

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

11.1

6.3

L04AD01

ATC

ciclosporin; systemic

2.6

6.3

137

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

9.3

6.3

R31

ICD-10 Finland

Unspecified haematuria

1.5

6.3

197

1361

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

18.1

6.3

R96

ICPC

Asthma

0.5

6.3

1203

1529, ,

Kela drug reimbursment

+∞

6.3

L01XE24

ATC

[U] ponatinib

+∞

6.3

L01EA04

ATC

bosutinib; oral

+∞

6.3

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

26.8

6.2

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

26.8

6.2

JFA73

NOMESCO Finland

Excision of lesion of small intestine

26.8

6.2

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

7.0

6.2

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

6.2

382

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

0.2

6.2

279

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

0.4

6.2

775

E86

ICD-10 Finland

Volume depletion

2.2

6.2

219

G20

ICD-10 Finland

Parkinson disease

0.2

6.2

314

RS221, ,

NOMESCO Finland

2.8

6.2

104

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

3.2

6.1

3AC01, ,

NOMESCO Finland

3.2

6.1

G04BD12

ATC

mirabegron; oral

0.6

6.1

105

1691

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.2

6.1

294

M70.6

ICD-10 Finland

Trochanteric bursitis

0.6

6.1

110

1750

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

3.8

6.1

TPH00

NOMESCO Finland

Phlebotomy

4.1

6.1

EB1VA, ,

NOMESCO Finland

0.6

6.1

1406

1AA09, ,

NOMESCO Finland

12.6

6.1

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

12.6

6.1

G47.3

ICD-10 Finland

Sleep apnoea

0.7

6.1

237

3214

ECB20

NOMESCO Finland

Oral alveoplasty

2.9

6.1

SPAT1229

SPAT

Assessment of need for aid

1.6

6.0

143

929

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

6.7

6.0

A21

ICPC

Risk factor for malignancy

6.7

6.0

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

6.7

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3012095) Magnesium [Moles/volume] in Serum or Plasma

988

3033

5.46

310.91

7.7

3.2

0.81

0.82

mmol/l

1.24

970

2850

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

887

2180

6.51

307.65

12.2

4.3

285.59

247.21

u/l

5.23

869

2056

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1809

9393

10.60

299.71

32.0

6.3

10.13

11.74

umol/l

12.17

1793

8942

(4035726) Immunohistochemistry procedure

658

1679

5.35

250.75

1.6

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1779

10121

7.80

234.77

38.6

9.0

3.59

4.15

e9/l

16.84

1756

8820

(3023368) Bacteria identified in Blood by Culture

1209

5128

4.43

234.44

6.2

4.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

676

2070

4.42

199.83

8.7

4.1

27.39

20.99

ug/l

0.30

607

1703

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1616

9132

4.99

196.20

16.1

6.9

1.21

mmol/l

0.05

1385

7783

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1505

8351

4.23

180.23

12.7

6.1

1.21

mmol/l

1.35

1474

7611

(3022096) Basophils/100 leukocytes in Blood

1438

7886

3.92

171.59

13.6

6.0

0.75

0.67

3.14

1417

7348

(3019069) Monocytes/100 leukocytes in Blood

1463

8141

3.96

170.09

14.3

6.4

8.90

8.78

0.65

1441

7601

(3006504) Eosinophils/100 leukocytes in Blood

1455

8112

3.90

167.60

13.8

6.1

2.71

2.83

1.17

1434

7563

(3002030) Lymphocytes/100 leukocytes in Blood

1470

8304

3.90

164.67

14.0

6.2

26.63

27.27

1.04

1447

7772

(3024561) Albumin [Mass/volume] in Serum or Plasma

1425

7924

3.77

162.77

11.4

4.9

33.20

35.18

g/l

30.15

1389

7385

(40760892) CBC W Ordered Manual Differential panel - Blood

1450

8190

3.79

160.77

16.2

6.3

—

(3018418) pH of Serum or Plasma

1106

5437

3.31

150.51

10.6

4.1

7.39

7.40

1.40

257

1042

(3006315) Basophils [#/volume] in Blood

1473

8676

3.64

146.70

12.1

5.8

0.04

e9/l

0.52

1374

7445

(3001604) Monocytes [#/volume] in Blood

1470

8657

3.63

146.21

12.1

5.8

0.61

0.60

e9/l

0.31

1375

7433

(3013115) Eosinophils [#/volume] in Blood

1497

8970

3.65

143.58

13.3

6.1

0.19

e9/l

0.03

1399

7806

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

217

318

7.53

143.34

2.6

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

249

425

6.55

142.47

2.7

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

1410

8193

3.44

141.15

12.5

6.0

57.35

57.59

0.27

1383

7666

(3019198) Lymphocytes [#/volume] in Blood

1478

8852

3.56

140.38

12.4

5.9

1.95

1.93

e9/l

0.05

1394

7771

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

251

443

6.33

138.80

2.7

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1170

6196

3.14

135.42

19.4

3.4

2.34

2.35

mmol/l

1.52

1130

5434

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

742

3032

3.30

134.86

2.7

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

216

355

6.70

127.91

9.6

5.3

314.28

823.53

iu/ml

0.72

(3022217) INR in Platelet poor plasma by Coagulation assay

1426

8684

3.23

124.69

10.6

16.5

1.20

1.31

inr

5.59

420

2490

(3004809) Band form neutrophils/100 leukocytes in Blood

195

302

7.05

122.06

7.7

3.7

1.96

1.28

1.83

186

275

(40758558) Short blood count panel - Blood

896

4456

2.83

109.91

31.9

6.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

212

397

5.85

109.62

1.7

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

130

144

9.59

107.67

1.9

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

184

306

6.52

107.33

2.9

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

184

306

6.52

107.33

2.9

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1841

13692

5.28

106.80

37.1

7.7

90.08

79.29

u/l

12.27

1822

12913

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

271

645

4.70

106.35

3.2

2.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

185

336

5.96

98.57

6.0

3.6

55.51

58.23

1.35

185

336

(3003458) Phosphate [Moles/volume] in Serum or Plasma

595

2511

2.95

97.37

8.9

5.8

1.02

1.03

mmol/l

0.46

570

2325

(3017181) Myelocytes/100 leukocytes in Blood

432

1530

3.33

95.62

9.1

4.1

1.44

0.86

3.85

315

554

(3035637) Corticotropin [Mass/volume] in Plasma

142

208

7.27

93.18

1.7

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

988

5482

2.58

93.11

9.1

3.1

42.25

34.58

u/l

1.71

954

5204

(3003434) Protein [Mass/volume] in Pleural fluid

155

253

6.56

91.86

1.4

1.5

36.49

32.43

g/l

3.39

148

228

(3013826) Glucose [Moles/volume] in Serum or Plasma

1527

10519

2.90

91.02

8.1

4.9

6.71

6.79

mmol/l

0.77

1501

9935

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

719

3488

2.66

88.58

10.2

3.1

2.48

2.46

mmol/l

4.63

687

3087

(3044640) Blood type and Crossmatch panel - Blood

999

5705

2.50

86.68

4.3

2.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

158

279

6.06

86.48

4.0

2.6

868.29

2140.33

u/ml

0.46

(3023199) Leukocytes [#/volume] in Pleural fluid

143

233

6.53

84.80

1.4

1.5

1693.25

1788.80

e6/l

0.12

113

163

(3028308) Erythrocytes [#/volume] in Pleural fluid

134

208

6.83

83.23

1.4

126318.25

114817.92

e6/l

0.06

118

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

505

2113

2.86

82.28

2.4

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

130

198

6.95

82.19

2.3

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

616

2857

2.67

82.10

3.2

2.1

29.76

29.96

0.30

604

2765

(3033658) Prothrombin time (PT) actual/Normal

848

4582

2.48

81.80

7.5

4.0

91.29

88.24

3.31

832

4477

(3002179) Metamyelocytes/100 leukocytes in Blood

382

1386

3.17

80.14

9.5

3.9

1.04

0.61

3.54

272

478

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

497

2109

2.80

78.44

2.4

1.8

—

(40768806) Pleura Pathology biopsy report

128

203

6.67

77.84

1.5

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

123

189

6.87

77.07

3.0

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

507

2213

2.73

75.43

5.3

2.6

1.95

1.83

1.82

474

1956

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

125

203

6.50

74.26

3.0

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

429

1729

2.89

74.21

9.9

7.6

9.20

10.17

mmol/l

2.16

418

1649

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

156

316

5.27

73.47

2.0

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

382

1452

3.02

73.45

9.5

4.1

0.18

0.10

1.80

267

478

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

948

5586

2.32

72.81

4.9

2.6

59.92

74.09

u/l

0.48

921

5161

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1428

17296

0.39

71.54

4.3

5.3

2.65

2.69

mmol/l

0.65

1242

15798

(3004789) Transferrin [Mass/volume] in Serum or Plasma

560

2634

2.56

71.05

2.6

2.21

2.30

g/l

3.04

537

2448

(3012441) Differential panel - Pleural fluid

121

200

6.37

70.62

1.4

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

90.20

70.47

12.5

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

136

253

5.69

70.30

2.1

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

535

2488

2.57

69.28

2.6

21.33

22.69

1.29

486

2122

(3042936) Bacteria identified in Isolate by Culture

553

2614

2.54

69.18

2.2

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

10.23

67.83

3.4

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

10.23

67.83

3.4

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

393

1581

2.85

67.70

5.6

2.2

402.90

370.48

nmol/l

2.75

384

1444

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

134

255

5.56

67.56

2.0

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

8.92

67.48

3.2

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

8.92

67.48

3.2

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

10.10

67.22

3.4

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

917

5463

2.25

66.99

3.9

3.3

52.91

81.27

e6/l

0.95

781

4231

(3042631) Mycobacterium sp identified in Specimen

134

257

5.52

66.98

2.3

2.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

106

164

6.77

65.90

2.9

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

106

164

6.77

65.90

2.9

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

106

164

6.77

65.90

2.9

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

577

2837

2.45

65.85

2.7

2.6

11.77

12.83

umol/l

2.92

558

2652

(3045142) Bone marrow Pathology biopsy report

123

223

5.81

65.29

1.6

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1375

16800

0.42

64.73

4.1

4.7

1.37

1.47

mmol/l

12.38

1204

15329

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

344

1320

2.94

64.45

1.9

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

403

1686

2.74

64.13

6.0

2.6

72.04

70.23

e9/l

0.42

311

1289

(3042111) Morphology [Interpretation] in Bone marrow Narrative

155

351

4.70

63.90

2.2

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

249

798

3.42

63.26

2.2

1.9

7.02

2.29

ug/l

0.42

235

716

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

419

1803

2.67

62.97

2.7

2.2

0.20

0.21

g/l

2.23

392

1694

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1400

16934

0.42

61.98

4.1

4.7

4.52

4.59

mmol/l

1.74

1230

15562

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

442

1982

2.58

60.88

5.6

2.7

10.48

8.78

umol/l

0.71

422

1759

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

132

285

4.89

57.56

1.3

1.4

108.91

128.11

u/ml

0.56

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

125

258

5.10

57.46

1.1

—

(3025159) Blasts/100 leukocytes in Blood

340

1374

2.78

57.39

9.2

4.2

0.62

0.31

0.40

225

402

(3030467) Casts [#/volume] in Urine by Automated count

835

5031

2.13

56.70

3.9

3.2

0.59

0.46

e6/l

0.49

714

3856

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

140

322

4.60

56.52

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

134

298

4.75

56.38

1.5

1.3

15.12

10.40

u/l

2.02

112

238

(3020630) Protein [Mass/volume] in Serum or Plasma

377

1637

2.61

55.01

3.9

2.9

64.21

66.48

g/l

5.93

361

1503

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

175

488

3.83

54.61

1.3

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1197

8326

2.09

54.48

4.4

2.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

139

330

4.45

53.90

1.3

—

18.19

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1314

16106

0.46

53.57

5.6

6.2

40.29

40.38

mmol/mol

0.12

1176

14795

(21494434) Karyotype in Bone marrow

106

201

5.51

53.54

1.5

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

9.53

52.93

1.7

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1497

11440

2.22

51.82

5.2

4.6

1088.63

1716.67

e6/l

0.29

168

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

746

4440

2.08

51.05

4.1

2.5

—

(3021589) Normoblasts [#/volume] in Blood

1111

7648

2.02

50.46

24.3

10.0

0.04

0.00

e9/l

2.82

996

6240

(3045788) Cell count panel - Pleural fluid

188

5.49

49.91

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

186

5.49

49.43

9.8

3.6

54.62

56.25

0.25

163

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1345

16254

0.47

49.39

3.9

4.2

1.47

1.29

mmol/l

5.15

1170

14703

(3026782) Osmolality of Urine

639

3640

2.11

48.71

3.5

3.0

533.94

541.98

mosm/kgh2o

0.44

590

3135

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

222

774

3.10

48.65

3.3

1.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

121

279

4.55

48.63

1.8

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

112

247

4.74

47.54

1.8

1.4

—

(36304419) Bacteria [Presence] in Urine

784

4860

2.01

47.03

3.9

3.2

—

(3037121) Protein [Mass/volume] in Urine

196

649

3.24

46.81

4.3

3.1

0.30

0.26

g/l

0.40

158

263

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

101

208

5.06

46.48

2.6

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

101

208

5.06

46.48

2.6

1.5

—

(3018095) Leukocytes [#/volume] in Urine

944

6292

1.95

45.39

4.5

3.8

67.77

124.36

e6/l

1.91

793

4539

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

203

710

3.07

44.12

3.5

64.09

2148.84

u/ml

0.86

177

609

(3008757) Leukocyte morphology finding [Identifier] in Blood

100

217

4.80

43.26

13.6

4.0

—

(3024471) HLA-A [Type]

10.44

43.20

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

252

1004

2.73

43.07

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

200

711

3.01

42.20

2.3

1.7

—

(40768804) Tissue Pathology biopsy report

1028

7176

1.89

41.73

2.7

2.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

154

477

3.41

40.85

2.3

1.6

—

(3035880) pH of Pleural fluid

107

6.44

40.32

1.3

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

299

1335

2.46

40.28

4.0

2.8

9.06

10.67

g/l

8.17

280

1218

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

161

519

3.29

40.05

1.8

1.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

107

261

4.27

39.97

6.1

2.2

301.40

66.40

u/ml

1.07

107

254

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

261

1103

2.57

39.48

1.6

1.5

—

(3024932) HLA-DR beta [Type]

9.98

39.27

1.2

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

630

3820

1.95

38.66

3.1

2.6

6.00

5.32

e6/l

0.32

591

3445

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

185

663

2.97

38.39

3.9

3.0

0.38

0.35

u/ml

0.65

115

386

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

224

895

2.69

37.90

2.0

1.8

1.61

1.53

g/l

0.37

197

774

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

266

1158

2.50

37.72

4.1

3.7

1.59

1.93

mmol/l

0.67

196

871

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

348

1707

2.26

37.62

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

328

1576

2.29

37.23

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

131

388

3.54

37.20

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

131

388

3.54

37.20

1.6

1.3

—

(3009343) pH of Capillary blood

272

1206

2.45

37.05

4.1

3.7

7.41

0.05

156

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

161

544

3.13

37.00

1.6

1.2

—

(3011412) CD3 cells [#/volume] in Blood

161

5.07

36.77

4.2

1.9

2.27

1.15

e9/l

0.45

145

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

318

1516

2.30

36.73

9.3

3.8

1.22

1.23

mmol/l

0.37

308

1325

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

513

2944

2.00

36.63

3.5

3.0

2.42

2.22

e6/l

0.20

335

1625

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

272

1222

2.42

35.94

4.1

3.7

5.08

5.16

kpa

0.87

254

1168

(40768441) Liver Pathology biopsy report

128

5.46

34.58

1.4

1.3

—

(3023419) Bacteria identified in Sputum by Culture

111

309

3.74

34.55

2.6

2.4

—

(3036489) Thrombin time

176

651

2.87

34.41

3.4

2.0

21.85

21.68

0.15

169

584

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

141

5.11

33.02

1.8

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

153

4.91

32.89

2.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

142

5.07

32.75

1.5

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

9.66

32.44

3.5

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

147

4.90

31.47

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.97

31.41

4.2

3.8

—

(3003396) Base excess in Arterial blood by calculation

398

2202

2.01

30.92

6.5

7.2

1.33

1.10

mmol/l

0.56

305

1746

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

7.00

30.17

2.5

1.8

44373.50

4114.22

u/ml

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

133

5.02

30.12

1.4

11.20

13.58

u/l

1.99

126

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

6.75

29.81

1.3

1.5

71.53

59.07

1.24

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

106

5.51

29.37

5.1

2.0

1224.27

537.11

e6/l

0.55

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

249

1172

2.28

29.30

1.8

1.6

—

(3012501) Base excess in Blood by calculation

122

402

3.17

29.18

6.5

4.9

2.83

2.53

mmol/l

0.55

278

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

392

2200

1.97

29.07

6.6

7.3

4.96

5.10

kpa

2.49

373

2104

(3027801) Oxygen [Partial pressure] in Arterial blood

391

2201

1.96

28.71

6.6

7.3

12.09

12.21

kpa

0.14

370

2103

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

104

315

3.43

28.50

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

11.26

28.48

2.2

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

317

1666

2.07

28.17

3.0

2.4

72.76

39.94

u/l

0.39

290

1433

(3028433) Virus identified in Specimen by Culture

6.95

28.05

1.6

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

151

4.56

27.67

1.5

1.4

35.33

33.52

u/l

0.14

119

(1616796) Gas panel - Central venous blood

118

394

3.12

27.60

4.8

4.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

227

1061

2.29

27.08

3.3

1.8

1.95

1.48

g/l

0.77

200

972

(3001964) Herpes simplex virus Ag [Presence] in Specimen

7.35

26.75

2.2

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1489

16804

0.56

26.67

5.0

4.9

6.09

6.02

mmol/l

1.08

1308

15195

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

7.95

26.43

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

312

1671

2.03

26.21

6.6

7.0

1.50

1.36

mmol/l

1.40

305

1632

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

103

5.26

26.04

1.8

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

103

5.26

26.04

1.8

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

294

3.38

25.86

1.2

312.92

265.04

u/ml

0.75

170

(40765096) Chromosome analysis panel by Banding

6.48

25.67

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

124

4.79

25.54

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

7.62

25.50

5.6

2.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

499

3146

1.78

25.26

3.3

2.8

1.20

1.14

e6/l

0.12

324

1821

(3010421) pH of Blood

129

477

2.82

25.15

6.3

4.5

7.42

0.51

123

428

(3001893) Eosinophils/100 leukocytes in Pleural fluid

6.67

25.15

1.2

1.6

2.87

3.26

0.07

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

783

5618

1.65

24.40

3.2

3.1

1567.24

1332.16

ng/l

0.75

717

4841

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

658

4523

1.68

24.18

2.2

3.63

3.02

mg/l

4.12

586

3839

(3002032) Base excess in Venous blood by calculation

314

1733

1.96

24.09

5.5

3.7

1.91

2.02

mmol/l

0.18

253

1458

(40767503) Oxygen content in Capillary blood by calculation

113

398

2.95

24.08

2.8

2.6

15.58

16.08

0.44

208

(3048929) Epstein Barr virus Ab [Presence] in Serum

116

415

2.91

24.03

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

115

411

2.91

23.87

2.3

2.7

40.00

33.99

umol/l

1.64

108

373

(3026008) Bacteria identified in Urine by Culture

770

5534

1.64

23.64

3.2

—

(3019225) pH of Specimen

335

1909

1.91

23.31

11.1

4.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

106

4.91

23.23

2.4

2.7

35.82

40.70

0.84

(3019060) Gas panel - Arterial blood

248

1280

2.07

22.89

4.0

4.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

169

747

2.38

22.84

4.7

4.0

24.75

24.90

mmol/l

0.28

156

702

(3022313) Gas panel - Capillary blood

190

888

2.26

22.56

4.4

3.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

5.54

22.46

1.6

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

126

4.46

22.28

2.7

1.8

64.94

73.03

1.63

116

(3026493) Urate [Moles/volume] in Serum or Plasma

675

4750

1.64

22.22

7.1

2.8

2911.40

5771.22

umol/l

1.07

611

4121

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

538

3577

1.69

22.06

4.5

3.9

423.66

391.21

ng/l

0.09

446

2933

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

208

1018

2.16

22.03

8.0

9.5

24.39

24.38

mmol/l

0.01

200

995

(3021447) Carbon dioxide [Partial pressure] in Venous blood

308

1740

1.91

21.91

5.6

3.7

5.75

5.85

kpa

0.84

303

1694

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1853

16889

2.31

21.90

46.4

15.6

27.29

25.12

mg/l

2.13

1799

13514

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

285

4788

0.53

21.86

1.6

1.7

1.80

1.36

mmol/l

3.00

231

3974

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

4.45

21.82

1.8

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

25.35

21.76

1.3

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

132

535

2.57

21.49

3.7

3.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1414

11917

1.64

21.38

5.5

4.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

913

6971

1.57

20.98

4.2

3.8

28.83

60.69

ng/l

2.06

783

5108

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

113

436

2.69

20.31

3.3

291.02

932.58

u/ml

0.52

105

405

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

763

5621

1.58

20.30

3.4

2.2

169.65

221.84

u/l

1.25

730

5272

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

182

3.66

20.09

2.8

2.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

115

454

2.63

19.75

1.6

1.3

26.04

33.64

iu/l

1.64

389

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

194

3.54

19.71

3.4

3.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

194

973

2.10

19.23

4.0

3.3

4.25

4.41

pmol/l

1.39

176

853

(3034426) Prothrombin time (PT)

6.54

19.21

1.0

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

337

2039

1.78

19.06

1.8

—

(1761868) Lipid panel - Serum or Plasma

362

5508

0.58

18.93

2.7

3.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

162

3.72

18.78

1.1

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

4.57

18.48

7.5

6.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

177

877

2.12

18.09

6.7

4.1

24.09

24.21

mmol/l

0.17

177

856

(3016502) Oxygen saturation in Arterial blood

326

1982

1.77

18.07

7.2

7.6

95.02

95.59

0.73

310

1910

(21494814) CD8 cells/100 lymphocytes in Specimen

5.29

17.99

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.20

17.67

1.2

747.46

67.77

ug/l

1.34

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

327

2.80

17.58

1.3

1.2

110.10

45.36

u/l

1.11

289

(3000919) Neutrophils/100 leukocytes in Pleural fluid

5.58

17.45

1.3

1.5

8.89

27.96

3.94

(40768793) Breast Pathology biopsy report

103

410

2.59

17.41

1.3

—

(3000012) Reticulocyte production index

283

2.90

16.95

5.4

2.1

—

(3000991) Gas panel - Venous blood

271

1594

1.81

16.72

9.5

8.3

—

(3042733) HLA Ab [Presence] in Serum

6.50

16.66

3.3

5.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

107

4.18

16.56

2.2

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

103

4.24

16.51

2.8

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

103

4.24

16.51

2.8

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

119

3.93

15.95

2.9

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

527

3753

1.55

15.40

2.2

1.8

2.31

1.31

mg/l

3.23

456

2906

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

12.42

15.36

1.1

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

4.47

15.21

1.5

2.0

99.84

99.47

0.02

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

20.20

15.10

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

106

4.03

15.07

2.2

1.3

—

(3025941) Bacteria identified in Stool by Culture

168

876

2.00

14.93

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

238

2.92

14.72

2.1

1.4

—

(3051651) Icteric interference index of Serum or Plasma

108

3.95

14.70

4.3

3.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

239

2.91

14.61

2.1

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

146

3.49

14.58

7.3

4.8

318.48

43.06

u/ml

0.74

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

241

2.89

14.39

2.1

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

405

2.44

14.39

2.5

2.3

123.59

129.71

g/l

1.15

302

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

101

4.02

14.35

1.6

6.25

6.55

u/l

0.03

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

269

1654

1.72

14.13

3.0

167.64

197.38

ng/l

0.88

246

1516

(3025468) Yersinia sp identified in Specimen by Organism specific culture

238

2.88

14.13

2.1

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

238

2.88

14.13

2.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.29

14.10

2.3

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.29

14.10

2.3

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

303

1931

1.67

13.93

4.7

3.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

240

2.85

13.92

2.1

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.20

13.69

3.6

3.7

—

(3000494) Fungus identified in Specimen by Culture

319

2078

1.64

13.43

2.4

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

108

498

2.24

13.23

3.1

3.3

24.39

25.21

mmol/l

1.05

103

491

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

391

2.39

13.12

2.0

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

5.49

13.07

1.1

1.4

79.58

88.00

0.44

(3009871) Measles virus Ab [Titer] in Serum

5.49

13.07

1.2

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.49

13.07

1.1

78.89

88.46

0.74

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

363

2.43

12.90

1.2

108.00

348.89

titre

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

274

2.65

12.82

1.2

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

5.37

12.78

1.1

90.28

106.74

0.97

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

10.11

12.48

1.5

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

100

459

2.24

12.40

1.5

2.0

10.61

11.92

mg/l

0.64

425

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.72

12.36

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.05

12.13

1.6

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

100

464

2.22

12.08

7.9

3.2

1.52

1.64

mg/l

0.90

419

(46235355) HIV 1 and 2 tests - Meaningful Use set

300

1983

1.60

11.81

1.4

1.6

—

(3021901) Oxygen saturation in Capillary blood

366

2.35

11.77

3.2

2.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.42

11.45

2.0

12068.00

27383.83

e6/l

0.25

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1111

0.33

11.44

1.3

1.8

—

(3002256) Pathology report gross observation

345

2372

1.55

11.44

1.4

1.3

—

(3044007) Cell count panel - Peritoneal fluid

4.86

11.44

2.2

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

160

3.05

11.37

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

279

1833

1.61

11.24

8.1

8.0

119.20

121.17

g/l

0.76

269

1782

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

228

2.68

11.21

1.1

1.2

1.33

4.16

u/ml

1.17

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

387

2.28

11.20

1.3

1.9

2.47

4.54

iu/l

2.73

132

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

17.13

11.19

1.1

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

151

3.09

11.19

2.1

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

228

1426

1.68

11.16

5.2

3.1

4.57

4.59

kpa

0.06

223

1385

(3023487) Leukocytes [#/volume] in Peritoneal fluid

4.10

11.14

2.1

2.2

1103.60

766.22

e6/l

0.30

(44786800) Granulocytes/100 leukocytes in Body fluid

11.21

11.04

1.2

1.6

22.20

16.73

0.20

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

261

2.54

10.88

8.3

6.7

10.99

12.00

mg/l

1.22

245

(3037522) Nuclear Ab [Titer] in Serum

325

2232

1.54

10.79

1.3

498.13

524.86

titre

0.08

510

(3048879) Bone marrow aspiration report

4.33

10.77

3.2

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

227

3443

0.62

10.61

1.2

1.02

1.48

u/ml

1.10

892

(40761536) Microorganisms panel - Urine sediment

227

1438

1.65

10.57

4.4

4.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.04

10.52

1.1

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

197

1204

1.71

10.50

5.5

6.7

24.88

24.56

mmol/l

0.59

184

1142

(21494755) Public health laboratory ask at order entry panel

1003

0.33

10.43

1.0

1.4

—

(3003181) Sodium [Moles/volume] in Urine

356

2.27

10.28

1.3

1.4

58.84

59.71

mmol/l

0.06

284

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

103

3.44

10.16

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

139

3.06

10.10

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

726

0.23

10.09

1.1

1.5

—

(3003694) ABO and Rh group [Type] in Blood

572

4439

1.40

10.05

1.5

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

391

5239

0.68

9.99

3.3

4.6

20.86

21.32

0.25

186

2711

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

224

2.59

9.99

1.1

1.2

2.72

6.23

u/ml

1.50

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

136

3.06

9.83

1.5

1.4

0.20

0.29

nmol/l

0.70

101

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

8.15

9.82

1.2

1.9

2.64

5.79

0.86

(3001122) Ferritin [Mass/volume] in Serum or Plasma

842

6981

1.36

9.76

3.2

2.8

328.10

143.30

ug/l

12.60

793

6386

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

166

2.81

9.52

1.1

1.2

103.22

94.88

1.23

158

(3000093) Morphology [Interpretation] in Blood Narrative

183

2.72

9.51

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

111

590

1.93

9.37

5.3

6.0

1.30

1.32

mmol/l

0.07

519

(3013512) EKG study

688

5557

1.36

9.33

5.4

4.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

311

2.26

9.01

1.1

1.2

241.06

220.24

miu/ml

0.12

127

(40757373) Influenza virus identified in Isolate

4.69

8.82

1.9

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

393

2.11

8.82

1.5

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

267

3769

0.66

8.77

2.6

3.2

0.89

0.76

ug/l

0.98

192

2639

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

222

2.47

8.67

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

158

2.76

8.63

1.1

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

128

2.93

8.29

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

165

1036

1.65

7.95

11.0

9.9

—

(3007566) Smooth muscle Ab [Titer] in Serum

458

1.96

7.94

1.1

1.2

168.00

90.31

titre

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

105

3.08

7.87

1.1

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

184

2.54

7.85

1.8

2.2

—

(3033799) Differential panel - Peritoneal fluid

3.74

7.63

1.8

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

483

6031

0.74

7.62

3.7

3.9

19.58

8.43

mg/mmol

3.24

322

3804

(40768795) Lymph node Pathology biopsy report

175

2.55

7.60

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

124

2.86

7.54

1.7

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

245

2.28

7.43

1.1

1.60

1.53

g/l

0.73

222

(40760409) HLA-A [Type] by High resolution

15.80

7.23

1.0

—

(3013862) HLA-DP [Type]

15.80

7.23

1.0

—

(40763590) HLA-DQ beta [Type]

15.80

7.23

1.0

—

(46236302) HLA-C [Type] by High resolution typing

15.80

7.23

1.0

—

(40760410) HLA-B [Type] by High resolution

15.80

7.23

1.0

—

(3012516) Albumin [Mass/volume] in Urine

459

5738

0.74

7.21

3.3

1230.01

302.15

mg/l

1.87

325

3663

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

295

2.14

7.15

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

398

1.97

7.12

1.4

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

476

5894

0.75

6.94

3.1

3.2

7.02

7.36

mmol/l

1.05

382

4952

(3019550) Sodium [Moles/volume] in Serum or Plasma

1857

17796

1.60

6.90

44.1

18.2

138.84

139.68

mmol/l

35.13

1837

17362

(3032352) Blasts [#/volume] in Cerebral spinal fluid

7.55

6.90

7.5

2.3

—

(3051611) Lipemic interference index of Serum or Plasma

190

2.40

6.88

4.3

3.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

260

2.19

6.88

1.2

1.1

—

(3014891) Appearance of Pleural fluid

6.11

6.77

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

7.19

6.70

1.7

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

7.19

6.70

1.7

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

7.19

6.70

1.7

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.01

6.66

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.01

6.66

1.1

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

122

744

1.68

6.60

1.5

1.8

43.35

38.63

u/l

1.80

105

651

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

3.12

6.59

1.2

1.1

151.42

83.69

u/l

1.78

(3019309) Folate [Moles/volume] in Red Blood Cells

444

3511

1.34

6.53

1.7

1.8

1181.08

1183.92

nmol/l

0.02

358

2639

(3020393) Adenovirus Ag [Presence] in Stool

10.05

6.53

1.9

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

3.09

6.47

1.2

1.1

73.12

27.23

u/l

1.70

(40758292) HTLV I+II Ab panel - Serum

5.71

6.45

1.4

1.5

—

(3019977) pH of Arterial blood

107

2.83

6.43

2.7

3.0

7.41

7.42

0.37

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

5.97

6.30

1.7

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1857

17841

1.56

6.28

45.0

18.4

4.01

3.98

mmol/l

4.68

1834

17387

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.13

6.09

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

100

2.83

6.00

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

631

0.37

5.88

2.1

1.8

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

6.88

5.73

1.6

2.3

1.04

1.11

mg/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

112

1741

0.62

5.64

1.6

1.5

—

(3017732) Neutrophils [#/volume] in Blood

170

1169

1.50

5.56

3.5

3.2

8.55

4.93

e9/l

0.59

146

914

(3016038) Potassium [Moles/volume] in Urine

128

2.52

5.54

1.2

36.11

33.91

mmol/l

0.20

113

(3020891) Body temperature

121

774

1.60

5.47

4.7

4.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

3.25

5.45

44.3

31.3

8.67

6.98

ug/l

3.11

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.88

5.43

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

5.20

5.39

1.7

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

140

2.38

5.07

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

722

0.46

4.98

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.35

4.93

1.3

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.88

4.93

1.0

1.1

1.03

1.05

ratio

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

5.44

4.91

1.2

1.1

64.71

75.20

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

416

1.76

4.81

1.2

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

11.47

4.78

2.3

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

132

896

1.51

4.63

3.9

2.7

1.16

1.15

0.02

132

890

(3021960) Folate [Moles/volume] in Serum or Plasma

522

4390

1.26

4.61

1.7

1.6

17.59

20.49

nmol/l

5.22

481

3706

(3008898) HLA-B27 [Presence]

477

0.37

4.56

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

1229

0.60

4.54

1.1

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

222

2.00

4.47

2.9

2.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

561

6523

0.81

4.46

3.8

5.3

2.54

3.01

ug/l

0.90

491

5815

(40760888) Immunoglobulin light chains.free panel - Serum

495

1.66

4.44

1.8

4.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.35

4.32

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1128

0.60

4.32

1.2

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

115

772

1.52

4.27

5.1

1.65

1.59

0.46

107

721

(3014007) Fractional oxyhemoglobin in Arterial blood

170

1233

1.41

4.25

10.0

9.0

92.60

93.99

1.18

170

1226

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.43

4.18

1.4

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.82

4.18

1.2

1.1

51.40

80.50

—

(3041096) Erythrocytes [Presence] in Urine by Automated

515

4367

1.24

4.18

4.1

3.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

127

876

1.48

4.14

4.0

2.7

0.66

0.64

0.40

127

871

(3039000) Anion gap in Blood

418

1.67

3.95

6.3

6.8

11.00

11.20

mmol/l

0.22

372

(3018572) Chloride [Moles/volume] in Blood

418

1.67

3.95

6.3

6.8

104.44

105.24

mmol/l

0.93

372

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

726

0.53

3.92

1.3

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.27

3.91

6.0

2.4

—

(3000060) B lymphocytes [#/volume] in Blood

3.80

3.89

5.3

2.0

120.00

222.67

e6/l

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

546

1.58

3.86

1.3

1.5

239.57

277.46

ug/g

0.92

328

(40768446) Kidney Pathology biopsy report

2.79

3.85

1.1

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

12.03

3.76

2.7

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

209

1.93

3.73

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

100

672

1.51

3.73

1.3

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

357

1.70

3.69

1.2

1.19

4.98

u/ml

—

(1002224) Polysomnography panel

566

0.49

3.65

1.1

—

(4200892) Spirometry reversibility

175

1311

1.37

3.64

1.7

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.49

3.63

1.7

2.6

1636.62

1449.13

u/ml

0.15

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

192

1461

1.35

3.61

3.6

3.9

103.92

92.00

ng/l

0.86

171

1267

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

299

1.76

3.61

1.1

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.66

3.56

3.4

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

183

1389

1.35

3.50

2.5

2.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

10.02

3.50

2.0

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

694

0.55

3.41

1.1

—

153.64

titre

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.11

3.37

1.0

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

165

1242

1.36

3.34

9.8

8.8

1.27

1.29

0.16

165

1232

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.93

3.30

1.2

1.5

12.18

2.97

ug/l

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

142

2.06

3.27

1.2

1.1

—

4.33

—

(4062490) Immunoglobulin typing, IgG

149

2.03

3.26

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

3.04

3.25

2.5

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

660

1.48

3.25

1.9

3.8

54.91

60.27

mg/l

0.18

541

(40765089) Chromosome analysis panel - Blood by G-banded

5.35

3.19

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.35

3.19

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

291

0.34

3.18

1.8

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.32

3.17

1.0

1.1

—

(3000492) Spirometry study

197

1539

1.31

3.12

2.3

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

344

0.40

3.08

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

496

1.53

3.06

1.1

—

(3022475) Manganese [Moles/volume] in Blood

7.52

3.05

1.3

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

117

846

1.41

3.04

4.4

3.9

50.84

48.58

0.47

117

835

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

817

0.61

3.02

1.3

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

490

1.53

3.01

1.1

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

161

1.94

3.00

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.30

2.99

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

501

1.52

2.94

1.1

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

522

4573

1.19

2.93

4.6

4.2

0.00

estimate

0.11

204

1509

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

659

1.45

2.91

1.9

3.8

33.55

81.97

mg/l

1.50

541

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

211

1680

1.29

2.91

2.2

2.4

8.95

7.20

ug/l

0.45

186

1498

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1140

10649

1.16

2.84

5.3

3.2

95.77

52.76

u/l

9.88

1081

9827

(4281824) Cell count and differential, peritoneal fluid

186

1.84

2.83

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

106

764

1.41

2.83

5.4

5.2

0.85

0.88

0.37

716

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

640

1.44

2.78

1.9

3.8

1.49

1.63

ratio

—

(3016750) Collection duration of Urine

117

2.06

2.77

1.7

2.1

475.71

484.73

min

0.17

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1849

18050

1.32

2.77

41.2

11.1

26.66

25.73

u/l

1.80

1832

17382

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

152

1.92

2.75

1.2

1.1

—

61.00

—

(3040151) Glucose [Moles/volume] in Capillary blood

210

1.78

2.75

5.2

6.7

7.02

7.43

mmol/l

0.47

177

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

445

1.52

2.72

1.2

2.26

3.77

u/ml

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.72

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1360

12912

1.17

2.63

7.5

4.0

15.22

14.92

pmol/l

3.71

1287

11624

(3024139) IgG subclass 3 [Mass/volume] in Serum

148

1.90

2.61

1.4

0.43

0.38

g/l

0.30

101

(3027135) IgG subclass 1 [Mass/volume] in Serum

148

1.90

2.61

1.4

7.87

6.81

g/l

0.49

102

(3028192) IgG subclass 2 [Mass/volume] in Serum

148

1.90

2.61

1.4

2.57

2.82

g/l

0.32

103

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.68

2.59

1.0

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

276

0.40

2.59

1.7

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

100

2.11

2.59

3.9

1.8

—

(3038026) Centromere Ab [Units/volume] in Serum

156

1.87

2.57

1.2

1.1

—

64.26

—

(3046861) Legionella sp Ag [Presence] in Urine

7.16

2.55

1.0

—

(3009261) Glucose [Presence] in Urine by Test strip

915

8452

1.15

2.55

4.2

3.8

0.00

0.01

estimate

1.08

227

1515

(3043410) Blood group antigens tested for on Red Blood Cells

2.51

2.53

3.1

2.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

453

1.50

2.52

1.2

4.49

8.80

u/ml

0.64

(3044941) Cell count panel - Synovial fluid

313

0.44

2.50

1.1

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

646

0.61

2.50

1.0

1.1

—

2.00

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

180

1.79

2.48

2.2

1.9

67.23

818.92

u/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

390

1.53

2.47

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

227

1.69

2.40

1.4

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

191

0.36

2.40

1.0

—

2.23

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

185

1487

1.27

2.40

7.6

2.7

52.83

63.18

ml/min/173m2

4.25

618

(4094501) Cardiovascular stress test using bicycle ergometer

514

0.58

2.38

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

386

1.52

2.37

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

338

1.55

2.36

1.4

1.5

117.48

233.49

pmol/l

1.44

333

(3000475) Leukocytes [#/volume] in Synovial fluid

474

0.56

2.34

1.4

1.7

11960.68

15463.02

e6/l

0.38

340

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

214

1.69

2.33

1.1

—

(40761511) CBC panel - Blood by Automated count

1788

17435

1.24

2.31

35.0

14.8

—

(3037756) Immunofixation for Serum or Plasma

446

1.47

2.30

1.5

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.22

2.30

1.4

1.2

3246.00

1232.10

u/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

215

1.69

2.29

1.3

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

215

1.69

2.29

2.3

1.12

1.47

g/24h

0.40

103

(3021601) Nitrite [Presence] in Urine by Test strip

900

8352

1.14

2.26

5.6

5.1

0.00

estimate

0.50

232

1583

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.90

2.25

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

287

1.58

2.23

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

231

2756

0.82

2.21

1.2

1.3

11.36

13.39

u/ml

0.15

1031

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.13

2.18

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

158

1.78

2.18

1.9

2.3

637.56

618.12

0.10

101

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.69

2.15

4.1

5.5

—

(3038515) Glucose [Moles/volume] in Venous blood

387

1.49

2.15

3.8

3.4

7.56

7.58

mmol/l

0.02

377

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.21

2.09

1.4

2.2

—

(3035350) Ketones [Presence] in Urine by Test strip

897

8355

1.13

2.07

4.2

3.8

0.00

estimate

0.23

243

1677

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.01

2.07

7.4

4.7

—

(3012565) Volume of 24 hour Urine

2.03

2.06

2.1

2.8

1808.89

1877.60

0.10

(3002385) Erythrocyte distribution width [Ratio]

1499

14435

1.15

2.05

56.2

18.5

15.69

15.21

4.13

1487

14177

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.51

2.01

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1675

16275

1.18

2.00

45.5

14.7

75.42

77.34

ml/min/173m2

3.20

1582

13541

(3017569) Oxygen content in Arterial blood

1.97

2.00

3.3

2.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

596

1.37

2.00

3.3

3.9

3.99

3.90

mmol/l

0.89

589

(3003338) MCHC [Mass/volume]

1317

13733

0.88

1.97

59.7

20.6

329.09

331.99

g/l

20.32

1306

13639

(4212803) Bone marrow aspirate examination

3.34

1.96

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

147

1183

1.26

1.93

2.2

11.10

12.63

nmol/l

1.55

138

1036

(3014271) Vancomycin [Susceptibility]

1.93

1.90

3.4

2.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.00

1.88

0.0

2.3

—

139.16

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

534

1.38

1.88

1.3

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

197

2347

0.82

1.88

13.3

7.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

475

1.40

1.87

4.9

4.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.65

1.86

1.0

1.1

—

(3004451) EKG impression Narrative

100

1.91

1.85

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

122

1.81

1.84

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.17

1.82

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

126

1004

1.27

1.81

1.2

162.63

137.37

iu/ml

0.20

374

(3044889) 12 lead EKG panel

1306

12510

1.13

1.79

5.6

4.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

253

2173

1.19

1.78

1.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

137

0.36

1.75

4.0

3.9

14.04

13.27

—

137

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.51

1.74

1.0

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

218

1.57

1.71

1.5

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

1.70

0.0

1.1

—

0.45

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

1.69

0.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.51

1.66

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

334

1.45

1.66

3.3

3.2

—

(3048689) Calprotectin [Mass/mass] in Stool

150

1812

0.81

1.66

2.2

2.3

250.32

151.97

ug/g

1.13

122

1433

(3052592) Norovirus Ag [Presence] in Stool

2.59

1.66

2.0

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.25

1.63

1.1

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

105

1.82

1.63

2.2

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

134

0.37

1.61

1.0

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

2.21

1.57

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

685

6362

1.12

1.56

4.5

4.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

409

0.63

1.55

1.3

1.5

—

(40762814) Titanium [Mass/volume] in Blood

0.00

1.52

0.0

2.2

—

3.25

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

251

1.48

1.4

1.6

0.97

0.88

g/l

0.11

190

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

727

1.28

1.46

3.1

2.7

3.37

2.97

g/l

2.19

661

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.80

1.43

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.31

1.43

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

2.26

1.40

1.6

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

189

2194

0.85

1.39

1.3

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

777

1.26

1.39

3.0

2.6

3.53

3.68

g/l

0.35

710

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

777

1.26

1.39

3.0

2.6

7.93

7.39

g/l

1.57

710

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

777

1.26

1.39

3.0

2.6

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.95

1.36

1.2

1.1

0.04

0.11

nmol/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.95

1.36

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

442

0.67

1.35

1.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.13

1.33

1.3

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.32

0.0

1.6

—

1.67

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

729

1.26

1.32

3.1

2.7

10.03

10.42

g/l

0.28

661

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

176

1.54

1.31

1.1

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

360

1.37

1.31

3.5

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.50

1.30

2.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.10

1.30

1.1

1.5

—

(40768443) Skin Pathology biopsy report

786

1.25

1.28

1.3

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.05

1.27

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.05

1.27

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.05

1.27

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.05

1.27

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

795

1.23

1.17

2.5

2.6

—

(3011985) Renin [Units/volume] in Plasma

224

1.44

1.14

1.7

1.3

33.96

55.29

mu/l

0.84

197

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.85

1.13

1.9

2.4

—

(3015736) pH of Urine

705

6657

1.09

1.10

3.8

3.5

5.94

5.81

0.33

382

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

193

1.46

1.09

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.19

1.08

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

579

1.25

1.05

3.0

2.6

0.39

0.02

g/l

0.46

540

(3005322) IgE [Units/volume] in Serum or Plasma

112

945

1.20

1.04

1.3

163.35

226.18

u/ml

0.72

867

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

116

982

1.19

1.04

2.5

2.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.92

1.02

1.1

1.4

—

127.33

titre

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

512

1.26

0.99

1.5

1.6

35.53

12.42

iu/ml

0.28

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

572

0.76

0.99

1.7

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

722

1.21

0.97

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

149

1.48

0.95

1.8

2.1

1.89

2.10

u/field

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.95

0.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.65

0.94

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.73

0.92

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

551

1.22

0.84

3.1

2.6

0.02

0.00

g/l

0.49

513

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

366

0.73

0.84

2.1

1.7

44.26

41.69

nmol/l

0.20

346

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.76

0.83

2.0

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.76

0.83

2.0

2.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

212

2343

0.89

0.83

3.5

4.7

29.59

32.86

4.62

155

1547

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.55

0.81

1.5

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

271

0.70

0.80

1.1

1.3

—

(4034850) Laboratory test

575

0.80

13.9

10.7

—

(40768797) Stomach Pathology biopsy report

278

2555

1.10

0.79

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.2

—

1.85

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.21

0.79

3.1

2.6

0.00

g/l

-0.00

512

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

667

1.19

0.78

3.6

2.7

0.98

1.28

g/l

0.34

586

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

461

0.78

0.77

1.3

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

1.52

0.75

1.1

1.3

1.14

1.11

nmol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.70

0.75

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.61

0.72

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.58

0.71

1.5

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

418

3933

1.08

0.71

1.6

1.7

30769704.23

24435939.34

pmol/l

0.07

338

3233

(40761535) Cells panel - Urine sediment

172

1552

1.12

0.70

4.3

3.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.93

0.70

1.0

2.5

41.00

44.61

umol/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.93

0.70

1.2

1.0

—

(3017704) Immunofixation for Urine

126

1.43

0.70

1.4

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.55

0.69

1.1

—

(3025577) Chromium [Mass/volume] in Blood

143

0.63

0.69

2.4

2.1

1.92

1.85

ug/l

—

122

(3026470) Cobalt [Mass/volume] in Blood

146

0.61

0.69

2.3

2.0

4.19

2.97

ug/l

—

134

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

883

9131

0.94

0.69

2.6

2.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

1.47

0.67

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.54

0.67

1.0

1.4

1.74

1.57

g/l

—

(3000330) Specific gravity of Urine by Test strip

106

933

1.14

0.65

3.9

3.6

—

(3021788) Differential panel - Synovial fluid

349

0.77

0.64

1.5

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

120

1.42

0.64

1.5

1.2

0.28

1.03

u/ml

0.75

(3025130) Human papilloma virus identified in Specimen

127

0.63

0.64

1.4

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

181

1.33

0.63

1.5

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.55

0.62

2.1

1.3

—

(3024263) Appearance of Synovial fluid

104

0.58

0.62

1.3

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.60

0.0

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

174

1.33

0.60

2.4

3.3

26.91

30.49

mg/l

0.10

134

(3002523) Influenza virus A Ag [Presence] in Specimen

183

1.32

0.59

1.5

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.54

0.59

2.5

1.7

18.13

15.06

pmol/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.54

0.59

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.53

0.59

1.2

275.89

223.22

iu/ml

0.20

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.58

0.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

395

1.19

0.54

3.2

1.3

3.66

3.80

mmol/l

0.65

368

(3038177) Helicobacter pylori Ab [Presence] in Serum

214

1.27

0.52

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

132

0.68

0.52

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.41

0.51

1.0

2.0

15.62

144.20

ug/l

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

270

0.78

0.51

1.9

196.43

212.46

pmol/l

0.39

252

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.46

0.50

1.3

1.5

0.38

0.36

ug/l

—

(3023420) DNA double strand Ab [Units/volume] in Serum

162

1.30

0.50

1.2

1.3

—

29.38

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.50

0.49

1.6

1.5

98.00

87.85

umol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.45

0.48

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.49

0.47

1.4

1.7

1596.57

84.36

nmol/24h

—

(3016018) Differential panel - Cerebral spinal fluid

191

1.26

0.46

3.2

1.5

—

(3023410) Appearance of Cerebral spinal fluid

191

1.26

0.46

5.7

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

486

1.16

0.46

2.2

94.44

101.07

ug/min

0.09

291

(3022621) pH of Urine by Test strip

126

1153

1.10

0.45

3.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

147

1.30

0.45

1.1

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

1.36

0.45

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

610

1.14

0.45

3.1

2.5

35.06

37.61

g/l

2.55

544

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.37

0.44

1.3

1.2

100.14

107.16

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

405

1.16

0.43

2.0

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

404

0.84

0.43

3.1

3.2

0.87

0.82

nmol/l

0.36

315

(3036180) Methadone [Presence] in Urine

1.56

0.42

1.0

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

267

1.20

0.42

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.41

0.42

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.43

0.41

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.3

—

(3001729) Color of Synovial fluid

0.00

0.41

0.0

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

1.4

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

105

1.34

0.41

1.6

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

109

1189

0.91

0.40

2.6

2.4

24.85

24.36

au/ml

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

238

0.80

0.40

1.3

1.2

0.65

0.66

nmol/l

0.05

223

(3013707) Erythrocyte sedimentation rate by Westergren method

1311

12916

1.04

0.40

5.4

4.2

21.46

13.00

mm/h

29.50

1211

11898

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

334

1.17

0.39

1.2

59.50

53.18

u/ml

—

(3051593) INR in Capillary blood by Coagulation assay

101

0.69

0.39

11.7

13.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.41

0.39

1.7

1.2

—

75.20

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.39

0.0

1.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

1866

18554

1.08

0.39

66.6

23.2

37.54

39.89

57.33

1769

17269

(4146454) Self-monitoring of blood glucose

226

0.79

0.39

2.5

2.6

—

(3027008) Opiates [Presence] in Urine

258

0.81

0.38

1.3

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.62

0.35

1.0

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.62

0.35

1.0

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.62

0.35

1.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.62

0.35

1.0

1.3

—

(3007461) Platelets [#/volume] in Blood

1866

18562

1.08

0.35

66.6

23.0

239.10

246.72

e9/l

3.99

1848

18068

(3011288) Drugs identified in Urine by Screen method

166

0.78

0.33

1.5

2.1

—

(3035941) MCH [Entitic mass]

1866

18567

1.07

0.33

66.1

22.9

30.75

30.42

7.63

1846

18277

(3024731) MCV [Entitic volume]

1866

18567

1.07

0.33

66.2

23.0

93.37

91.49

34.81

1847

18279

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1547

15615

0.96

0.32

8.1

4.8

2.29

2.06

mu/l

1.55

1443

14153

(3010813) Leukocytes [#/volume] in Blood

1866

18568

1.07

0.32

66.5

23.1

7.37

6.72

e9/l

2.41

1842

18012

(3026361) Erythrocytes [#/volume] in Blood

1866

18569

1.07

0.32

66.5

23.0

4.08

4.45

e12/l

133.57

1843

18012

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

219

0.82

0.31

1.3

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.32

0.30

1.0

1.9

1.46

1.31

ug/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

381

1.13

0.30

1.3

1.6

0.83

0.82

nmol/l

0.05

308

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

129

1.24

0.30

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

196

0.81

0.30

1.0

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.29

0.30

2.2

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1866

18574

1.07

0.30

66.7

23.2

124.11

134.63

g/l

142.47

1845

18286

(3016879) Cocaine [Presence] in Urine

239

0.84

0.29

1.4

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

162

0.80

0.28

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

958

0.93

0.27

1.2

1.3

—

(3028300) Cannabinoids [Presence] in Urine

258

0.85

0.27

1.3

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

104

1.25

0.26

1.7

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.30

0.26

1.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.67

0.25

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

256

0.86

0.25

1.3

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

773

7595

1.03

0.24

2.0

87.50

94.16

pmol/l

3.80

489

3934

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

388

1.11

0.24

3.6

1.4

7.82

36.47

e6/l

1.08

295

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

388

1.11

0.24

3.7

1.5

119.58

803.43

e6/l

1.28

309

(3003327) Ova and parasites identified in Stool by Light microscopy

465

1.10

0.24

1.9

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.71

0.24

1.2

—

(3027944) Amphetamines [Presence] in Urine

254

0.86

0.23

1.3

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.32

0.23

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

209

1.15

0.23

1.2

1.4

302.05

313.28

pmol/l

0.06

183

(40759836) Histone Ab [Presence] in Serum by Immunoblot

125

1.20

0.22

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

125

1.20

0.22

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

125

1.20

0.22

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

705

7173

0.97

0.22

2.5

2.2

75.61

78.67

nmol/l

2.15

650

6370

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

373.10

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

512

0.92

0.21

1.3

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.20

0.0

1.1

—

0.43

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.20

0.0

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

111

0.81

0.20

1.2

1.6

84.44

90.03

umol/l

—

111

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.20

0.19

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

127

1.18

0.19

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

127

1.18

0.19

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

127

1.18

0.19

1.1

—

(3045414) Leukocytes [Presence] in Urine

797

0.94

0.19

1.8

1.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

109

1.19

0.18

2.0

2.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

0.73

0.17

1.0

1.1

—

547.54

—

(3006653) Thiamine [Moles/volume] in Blood

0.80

0.14

3.0

1.3

216.71

136.34

nmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.80

0.14

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.79

0.14

1.9

1.3

134.76

164.17

pmol/l

—

(44813793) Dust mix specific IgE antibody measurement

0.82

0.13

1.0

—

(3047189) Immunofixation for 24 hour Urine

100

0.80

0.13

1.4

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

219

1.10

0.12

1.2

2.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

175

1706

1.03

0.11

1.6

1.7

1.57

1.54

0.19

145

1451

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.16

0.11

1.0

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

106

1.13

0.09

3.3

2.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

232

1.08

0.09

1.5

1.6

58.73

60.72

0.09

144

(3005570) Glucose [Moles/volume] in Urine

176

0.91

0.09

2.7

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

305

3094

0.98

0.09

1.7

1.5

2.35

2.57

g/l

1.33

227

1853

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.07

0.08

1.0

1.1

1285.67

1616.34

miu/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.03

0.08

1.0

1.1

—

(3022145) Colonoscopy Study observation

195

1985

0.98

0.08

1.2

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

282

2860

0.98

0.08

1.3

39.85

36.99

iu/ml

0.14

954

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

174

0.92

0.07

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.80

0.07

1.0

1.3

137.67

171.88

mmol/24h

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

0.80

0.07

1.5

2.0

17.83

6.33

nmol/l

—

(3014051) Protein [Presence] in Urine by Test strip

479

0.96

0.07

2.3

2.5

—

(3024928) Oxygen saturation in Venous blood

412

1.04

0.07

5.1

3.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.84

0.07

1.9

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.88

0.06

1.0

1.1

—

12.22

—

(3045716) Anion gap in Serum or Plasma

0.89

0.06

1.5

2.8

8.28

9.86

mmol/l

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.85

0.06

1.6

1.2

1030.75

407.28

u/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

100

1.10

0.05

2.5

2.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

201

0.94

0.04

1.3

1.2

—

nmol/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

407

4044

1.01

0.04

3.9

3.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

160

1.06

0.04

1.4

1.3

1.06

1.43

nmol/l

0.85

140

(3028707) Methadone [Presence] in Urine by Screen method

121

1.07

0.03

1.0

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

240

1.04

0.03

1.4

1.5

—

(3044927) Protein electrophoresis panel - Urine

219

0.96

0.03

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

367

3685

1.00

0.02

4.7

4.2

1.02

kg/l

0.31

549

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

242

1.03

0.02

1.7

2.4

41.59

24.33

mg/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

105

0.95

0.00

1.2

1.3

11.16

9.67

mmol/l

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

171

0.99

0.00

1.4

22.00

31.72

—

104

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

106

1.04

0.00

1.1

—

(3011648) Oxygen content in Venous blood

156

1.03

0.00

10.6

2.6

9.66

11.26

0.73

156

(3045424) Erythrocytes [Presence] in Urine

296

1.01

0.00

1.6

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

102

0.98

0.00

2.2

2.0

—

39.30

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

17.76

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.9

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

1.00

-0.00

1.2

1.5

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.1

—

(3006462) Nitrate [Presence] in Urine

0.92

-0.00

3.6

3.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

2.43

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.01

-0.00

1.1

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

2.67

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

-0.00

0.0

1.3

—

91.00

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.56

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

390

1.00

-0.00

2.5

3.8

28.35

26.59

mg/l

0.09

236

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_L01XE – L01XE Protein kinase inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

L01XE Protein kinase inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for L01XE Protein kinase inhibitors (RX_L01XE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints